Your browser doesn't support javascript.
loading
Cannabis positivity rates in 17 emergency departments across the United States with varying degrees of marijuana legalization.
Tolan, Nicole V; Krasowski, Matthew D; Mathias, Patrick C; Wiencek, Joesph R; Babic, Nikolina; Chai, Peter R; Chambliss, Allison B; Choucair, Ibrahim; Demetriou, Christiana A; Erickson, Timothy B; Feldhammer, Matthew; French, Deborah; Hayes, Bryan D; Kang, Phillip; El-Khoury, Joe M; Knezevic, Claire E; Monte, Andrew; Nerenz, Robert D; Okorodudu, Anthony O; Roper, Stephen M; Saitman, Alec; Thiriveedhi, Vamsi; Uljon, Sacha N; Vest, Alexis; Woodworth, Alison; Yu, Min; Melanson, Stacy E F.
Afiliação
  • Tolan NV; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Krasowski MD; Harvard Medical School, Boston, MA, USA.
  • Mathias PC; Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
  • Wiencek JR; Department of Laboratory Medicine and Pathology, Department of Biomedical Informatics and Medical Education, University of Washington School of Medicine, Seattle, WA, USA.
  • Babic N; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Chai PR; Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA.
  • Chambliss AB; Harvard Medical School, Boston, MA, USA.
  • Choucair I; Department of Emergency Medicine, Division of Medical Toxicology, Brigham and Women's Hospital, Boston, MA, USA.
  • Demetriou CA; The Koch Institute for Integrated Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Erickson TB; The Fenway Institute, Boston, MA, USA.
  • Feldhammer M; Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
  • French D; Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA.
  • Hayes BD; Department of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus, USA.
  • Kang P; Harvard Medical School, Boston, MA, USA.
  • El-Khoury JM; Department of Emergency Medicine, Division of Medical Toxicology, Brigham and Women's Hospital, Boston, MA, USA.
  • Knezevic CE; Harvard Humanitarian Initiative, Cambridge, MA, USA.
  • Monte A; Department of Pathology and Laboratory Medicine, University of Florida College of Medicine - Jacksonville, Jacksonville, FL, USA.
  • Nerenz RD; Department of Laboratory Medicine, University of San Francisco, San Francisco, CA, USA.
  • Okorodudu AO; Harvard Medical School, Boston, MA, USA.
  • Roper SM; Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USA.
  • Saitman A; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Thiriveedhi V; Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA.
  • Uljon SN; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Vest A; University of Colorado Anschutz, Aurora, CO, USA.
  • Woodworth A; Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.
  • Yu M; Department of Pathology and Laboratory Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Melanson SEF; University of Texas Medical Branch, Galveston, TX, USA.
Clin Toxicol (Phila) ; 61(4): 248-259, 2023 04.
Article em En | MEDLINE | ID: mdl-37129223
ABSTRACT

BACKGROUND:

Many states in the United States have progressed towards legalization of marijuana including decriminalization, medicinal and/or recreational use. We studied the impact of legalization on cannabis-related emergency department visits in states with varying degrees of legalization.

METHODS:

Seventeen healthcare institutions in fifteen states (California, Colorado, Connecticut, Florida, Iowa, Kentucky, Maryland, Massachusetts, Missouri, New Hampshire, Oregon, South Carolina, Tennessee, Texas, Washington) participated. Cannabinoid immunoassay results and cannabis-related International Classification of Diseases (ninth and tenth versions) codes were obtained for emergency department visits over a 3- to 8-year period during various stages of legalization no state laws, decriminalized, medical approval before dispensaries, medical dispensaries available, recreational approval before dispensaries and recreational dispensaries available. Trends and monthly rates of cannabinoid immunoassay and cannabis-related International Classification of Diseases code positivity were determined during these legalization periods.

RESULTS:

For most states, there was a significant increase in both cannabinoid immunoassay and International Classification of Diseases code positivity as legalization progressed; however, positivity rates differed. The availability of dispensaries may impact positivity in states with medical and/or recreational approval. In most states with no laws, there was a significant but smaller increase in cannabinoid immunoassay positivity rates.

CONCLUSIONS:

States may experience an increase in cannabis-related emergency department visits with progression toward marijuana legalization. The differences between states, including those in which no impact was seen, are likely multifactorial and include cultural norms, attitudes of local law enforcement, differing patient populations, legalization in surrounding states, availability of dispensaries, various ordering protocols in the emergency department, and the prevalence of non-regulated cannabis products.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Canabinoides / Cannabis / Maconha Medicinal Tipo de estudo: Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Clin Toxicol (Phila) Assunto da revista: TOXICOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Canabinoides / Cannabis / Maconha Medicinal Tipo de estudo: Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Clin Toxicol (Phila) Assunto da revista: TOXICOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos